Search Results - "Uchikawa, Shinichiro"

Prediction of 1-year clinical outcomes using the SYNTAX score in patients with prior heart failure undergoing percutaneous coronary intervention: sub-analysis of the SHINANO registry by Minamisawa, Masatoshi, Miura, Takashi, Motoki, Hirohiko, Kobayashi, Hideki, Kobayashi, Masanori, Nakajima, Hiroyuki, Kimura, Hikaru, Akanuma, Hiroshi, Mawatari, Eiichiro, Sato, Toshio, Hotta, Shoji, Kamiyoshi, Yuichi, Maruyama, Takuya, Watanabe, Noboru, Eisawa, Takayuki, Aso, Shinichi, Uchikawa, Shinichiro, Senda, Keisuke, Morita, Takehiro, Hashizume, Naoto, Abe, Naoyuki, Ebisawa, Soichiro, Izawa, Atsushi, Miyashita, Yusuke, Koyama, Jun, Ikeda, Uichi

“…Although coronary artery disease (CAD) is common in patients with heart failure (HF), little is known about the prognostic significance of coronary lesion…”
Get full text

Predictive Value of Combining the Ankle-Brachial Index and SYNTAX Score for the Prediction of Outcome After Percutaneous Coronary Intervention (from the SHINANO Registry) by Ueki, Yasushi, MD, Miura, Takashi, MD, Miyashita, Yusuke, MD, PhD, Motoki, Hirohiko, MD, PhD, Shimada, Kentaro, MD, PhD, Kobayashi, Masanori, MD, Nakajima, Hiroyuki, MD, Kimura, Hikaru, MD, Akanuma, Hiroshi, MD, Mawatari, Eiichiro, MD, PhD, Sato, Toshio, MD, Hotta, Shoji, MD, Kamiyoshi, Yuichi, MD, PhD, Maruyama, Takuya, MD, Watanabe, Noboru, MD, PhD, Eisawa, Takayuki, MD, Aso, Shinichi, MD, PhD, Uchikawa, Shinichiro, MD, PhD, Hashizume, Naoto, MD, Sekimura, Noriyuki, MD, Morita, Takehiro, MD, Ebisawa, Soichiro, MD, Izawa, Atsushi, MD, PhD, Koyama, Jun, MD, PhD, Ikeda, Uichi, MD, PhD

“…The Synergy Between PCI With TAXUS and Cardiac Surgery (SYNTAX) score is effective in predicting clinical outcome after percutaneous coronary intervention…”
Get full text

In-Hospital Clinical Outcomes of Elderly Patients (≥80 Years) Undergoing Percutaneous Coronary Intervention by Miura, Takashi, Miyashita, Yusuke, Motoki, Hirohiko, Shimada, Kentaro, Kobayashi, Masanori, Nakajima, Hiroyuki, Kimura, Hikaru, Akanuma, Hiroshi, Mawatari, Eiichiro, Sato, Toshio, Hotta, Shoji, Kamiyoshi, Yuichi, Maruyama, Takuya, Watanabe, Noboru, Eisawa, Takayuki, Aso, Shinichi, Uchikawa, Shinichiro, Hashizume, Naoto, Sekimura, Noriyuki, Morita, Takehiro, Ebisawa, Soichiro, Izawa, Atsushi, Tomita, Takeshi, Koyama, Jun, Ikeda, Uichi

“…Background: The clinical outcomes of elderly patients (≥80 years old) undergoing percutaneous coronary intervention (PCI) has not been well established,…”
Get full text

Comparison of mid-term outcomes between patients with and without atrial fibrillation undergoing coronary stenting in the second-generation drug-eluting stent era: from the SHINANO registry by Miura, Takashi, Miyashita, Yusuke, Motoki, Hirohiko, Kobayashi, Hideki, Kobayashi, Masanori, Nakajima, Hiroyuki, Kimura, Hikaru, Akanuma, Hiroshi, Mawatari, Eiichiro, Sato, Toshio, Hotta, Shoji, Kamiyoshi, Yuichi, Maruyama, Takuya, Watanabe, Noboru, Eizawa, Takayuki, Aso, Shinichi, Uchikawa, Shinichiro, Hashizume, Naoto, Senda, Keisuke, Morita, Takehiro, Ebisawa, Soichiro, Izawa, Atsushi, Koyama, Jun, Ikeda, Uichi

“…Little is known about the mid-term outcomes of patients with atrial fibrillation (AF) who undergo coronary stenting in the second-generation drug-eluting stent…”
Get full text

Malignant pericardial tamponade in a patient with hormone-refractory prostate cancer by Minagawa, Tomonori, Murata, Yasushi, Uchikawa, Shinichiro, Uehara, Takeshi

“…An 82-year-old man who was receiving treatment for prostate cancer and cholangiocellular carcinoma was admitted to our hospital because of chest discomfort and…”
Get full text

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy by Docherty, Kieran F, Jhund, Pardeep S, Bengtsson, Olof, DeMets, David L, Inzucchi, Silvio E, Køber, Lars, Kosiborod, Mikhail N, Langkilde, Anna Maria, Martinez, Felipe A, Sabatine, Marc S, Sjöstrand, Mikaela, Solomon, Scott D, McMurray, John J V

“…To determine whether the benefits of dapagliflozin in patients with heart failure and reduced ejection fraction (HFrEF) and type 2 diabetes in the…”
Get full text

Coronary microvascular response to intracoronary administration of nicorandil by Hongo, Minoru, Takenaka, Hiroaki, Uchikawa, Shinichiro, Nakatsuka, Tatsuya, Watanabe, Noboru, Sekiguchi, Morie

“…Nicorandil is an antianginal drug that causes potent coronary vasodilation of both epicardial and resistance vessels. To measure the dose-response kinetics of…”
Get full text